74 filings
Page 2 of 4
8-K
khm52dw2klukewtw5s
20 Oct 21
F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics
9:01am
8-K
xf6poz1v
17 Aug 21
Entry into a Material Definitive Agreement
4:02pm
8-K
r1264qse96e47alc fc
12 Aug 21
F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
10:08am
8-K
q8gze
14 Jul 21
F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
5:21pm
8-K
9uw369kar90hkrnsqv
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
c9u746w stv7e
17 May 21
F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
8:35am
8-K
0o8f7bs57
10 May 21
F-star Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
12:00am
8-K
ex8k m1180eghcp9skb
6 May 21
Termination of a Material Definitive Agreement
4:33pm
8-K
nnby2 qf5arbm9q4
14 Apr 21
Other Events
12:00am
8-K
lw05b0rzshw
5 Apr 21
Next Generation Immunotherapies. Overcoming Cancer. Full-Year 2020 Financial Results and Corporate Update 29th March 2021
4:03pm
8-K
0wr81
5 Apr 21
Changes in Registrant's Certifying Accountant
4:01pm
8-K
pwspzyxmb6t8ss
29 Mar 21
F-star Therapeutics Reports Full-Year 2020 Financial Results and Provides Corporate Update
8:15am
8-K/A
r3xbq 5uiw2scq5s9jaq
5 Feb 21
Other Events
4:49pm
8-K
zuhae1hk2 dg
4 Jan 21
F-star Therapeutics Announces First Patient Dosed in FS222 Phase 1 Clinical Trial
4:01pm
8-K
pvtjbq 4pei0lgc
4 Dec 20
F-star Therapeutics Announces First Patient Dosed in First-in-Class
11:55am
8-K
eztvullhrn
25 Nov 20
F-star Therapeutics Announces Clearance of
4:40pm
8-K
kges8 b46gwbg8jn
20 Nov 20
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
4:41pm
8-K
lupr0qs59of
9 Nov 20
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
8:01am
8-K
rkmokyzcig0in9vik
12 Aug 20
Regulation FD Disclosure
8:00am
8-K
50h9zd6o
10 Aug 20
Spring Bank Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Results
4:12pm